Ekocorp

Ekocorp EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Ekocorp (EKOCORP.NL) as of Oct 23, 2026 is 100.28. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 79.50 — a change of 26.15% (higher).

EV/OCF

100.28

YoY

26.15%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Ekocorp is 2020 100.28 . EV/OCF (Enterprise Value to Operating Cash Flow) of Ekocorp was 2019 79.50 . It decreases by 26.15% higher compared to the previous year.

The Ekocorp EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2015
-4.95 NGN
Jan 1, 2016
29.24 NGN
Jan 1, 2017
342.69 NGN
Jan 1, 2018
47.82 NGN
Jan 1, 2019
79.50 NGN
Jan 1, 2020
100.28 NGN
The Ekocorp EV/OCF history
YEAREV/OCFYoY
100.28+26.15%
79.50+66.26%
47.82-86.05%
342.69+1,071.84%
29.24-690.75%
-4.95—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Ekocorp is 100.28 in 2020.

EV/OCF (Enterprise Value to Operating Cash Flow) of Ekocorp changed from 79.50 to 100.28, representing a 26.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Ekocorp since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Ekocorp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ekocorp

All Key Metrics — Ekocorp